Goldman Sachs added Watson Pharmaceuticals (NYSE: WPI) to Conviction Buy List with a price target of $87, suggesting 25.7% upside.
This article: 239 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE